Becton, Dickinson and - BDX Competitors

Becton, Dickinson and (NYSE:BDX) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, community ranking, analyst recommendations, valuation, risk and profitability.

Is BDX or BSX more profitable?

Becton, Dickinson and has a net margin of 8.47% compared to Boston Scientific's net margin of 5.50%. Boston Scientific's return on equity of 14.29% beat Becton, Dickinson and's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and	8.47%	13.52%	6.36%
Boston Scientific	5.50%	14.29%	7.67%

Does the media refer more to BDX or BSX?

In the previous week, Boston Scientific had 19 more articles in the media than Becton, Dickinson and. MarketBeat recorded 31 mentions for Boston Scientific and 12 mentions for Becton, Dickinson and. Becton, Dickinson and's average media sentiment score of 0.81 beat Boston Scientific's score of 0.21 indicating that Becton, Dickinson and is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	5 Very Positive mention(s)	3 Positive mention(s)	17 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Neutral

Do analysts recommend BDX or BSX?

Becton, Dickinson and presently has a consensus target price of $271.89, suggesting a potential upside of 13.35%. Boston Scientific has a consensus target price of $51.50, suggesting a potential upside of 5.77%. Given Becton, Dickinson and's higher probable upside, research analysts plainly believe Becton, Dickinson and is more favorable than Boston Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Boston Scientific	0 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more risk & volatility, BDX or BSX?

Becton, Dickinson and has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.

Does the MarketBeat Community prefer BDX or BSX?

Boston Scientific received 368 more outperform votes than Becton, Dickinson and when rated by MarketBeat users. Likewise, 69.96% of users gave Boston Scientific an outperform vote while only 62.42% of users gave Becton, Dickinson and an outperform vote.

Company	Underperform	Outperform
Becton, Dickinson and	Outperform Votes 573 62.42%	Underperform Votes 345 37.58%
Boston Scientific	Outperform Votes 941 69.96%	Underperform Votes 404 30.04%

Which has stronger earnings & valuation, BDX or BSX?

Becton, Dickinson and has higher revenue and earnings than Boston Scientific. Becton, Dickinson and is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and	$18.87 billion	3.61	$1.78 billion	$5.30	45.26
Boston Scientific	$12.68 billion	5.51	$698 million	$0.45	108.20

Do insiders & institutionals have more ownership in BDX or BSX?

87.1% of Becton, Dickinson and shares are owned by institutional investors. Comparatively, 90.2% of Boston Scientific shares are owned by institutional investors. 0.3% of Becton, Dickinson and shares are owned by company insiders. Comparatively, 0.7% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Boston Scientific beats Becton, Dickinson and on 13 of the 19 factors compared between the two stocks.